O
39
4
L
51
2
WMB
59
4
AVGO
63
-3
NDAQ
74
3
FOX
51
-2
AAPL
33
-6
STZ
30
-3
CNP
52
-10
LNC
52
9
HPE
50
-16
GPC
44
-3
ROST
41
-19
URBN
84
9
AN
49
3
TJX
51
7
ES
39
4
NWS
84
20
HPQ
57
-3
VTR
43
2
O
39
4
L
51
2
WMB
59
4
AVGO
63
-3
NDAQ
74
3
FOX
51
-2
AAPL
33
-6
STZ
30
-3
CNP
52
-10
LNC
52
9
HPE
50
-16
GPC
44
-3
ROST
41
-19
URBN
84
9
AN
49
3
TJX
51
7
ES
39
4
NWS
84
20
HPQ
57
-3
VTR
43
2
Financhill
Back

SpringWorks Therapeutics Stock Predictions

Disrupting a Trillion-Dollar Industry

Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
29

SWTX
SpringWorks Therapeutics

Last Price:
$46.47
Seasonality Move:
-7.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq

SpringWorks Therapeutics Stock Forecast

  • Over the next 52 weeks, SpringWorks Therapeutics has on average historically risen by 16.7% based on the past 5 years of stock performance.
  • SpringWorks Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is SpringWorks Therapeutics Stock Undervalued?
    The current SpringWorks Therapeutics [SWTX] share price is $46.48. The Score for SWTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will SpringWorks Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, SpringWorks Therapeutics has on average historically risen by 16.7% based on the past 5 years of stock performance.

SpringWorks Therapeutics Stock Rating

Sell
29
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics overpriced?

  • SpringWorks Therapeutics has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

SpringWorks Therapeutics Stock Price History

Is SWTX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
springworkstx.com

52-Week Data

52-Week High:
62.00
52-Week Low:
28.21

Prediction Charts

Market Cap:
3.5B
Price in USD:
46.48
Volume:
5.9M
Beta:
0.91

Technical Analysis

SMA50:
44.36
SMA100:
44.38
SMA200:
40.06
52-Wk Change:
8.57%

Stock Predictions

  • Is SpringWorks Therapeutics stock public?
    Yes, SpringWorks Therapeutics is a publicly traded company.
  • What is the SpringWorks Therapeutics stock quote today?
    The SpringWorks Therapeutics stock price is 46.48 USD today.
  • How to buy SpringWorks Therapeutics stock online?
    You can buy SpringWorks Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-6 46.23 46.16 46.26 46.15
May-7 46.22 46.20 46.27 46.10
May-8 46.18 46.20 46.23 46.14
May-9 46.19 46.26 46.26 46.16
May-12 46.18 46.12 46.21 46.05
May-13 46.14 46.22 46.28 46.11
May-14 46.22 46.22 46.28 46.16
May-15 46.23 46.08 46.31 46.07
May-16 46.18 46.11 46.21 46.09
May-19 46.14 46.27 46.29 46.09
May-20 46.24 46.31 46.33 46.20
May-21 46.23 46.21 46.37 46.21
May-22 46.23 46.27 46.31 46.21
May-23 46.26 46.48 46.49 46.25

SpringWorks Therapeutics Earnings

SpringWorks Therapeutics Earnings Report: Per Share SpringWorks Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

SpringWorks Therapeutics Forecast Revenue Growth

SpringWorks Therapeutics Stock Analysis: Historical quarterly revenues per share for SpringWorks Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.00 per share, and an increase next year of $3.01 per share.

* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.